In this talk, we’ll delve into the advantages of SimpleStep ELISA technology, which combines the specificity of recombinant antibodies with the CaptSure immobilization technology. We’ll highlight innovation in high-throughput immunoassays, with a particular focus on SureFire® – the pharmaceutical industry’s go-to platform for high-throughput screening in drug discovery research – as well as a new 384-well format of SimpleStep ELISA. Finally, we’ll examine how our immunoassays effectively solve specific customer challenges, enhancing research efficiency and precision within the field